canada glp 1 approves first generic GLP-1 drug in G7 NAD Patches Canada - Maximum

With the news that consumer food spending is in decline, attributed to the growing popularity of Ozempic and other similar medications, we dive into the impact of GLP-1 on the food industry

Life After The Shot: The Hidden Psychology of GLP-1 Success: Navigating Identity, Relationships, and Mental Space After GLP-1 Weight Loss When Food Noise

This narrative review examines how digital promotion, gray-market access, self-injection, stacking, informal titration, product-quality uncertainty, regulatory ambiguity, and weak pharmacovigilance interact to normalize poorly traceable peptide products outside clinical supervision

2023;135:190-201

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course